Fatty acid synthetase expression in triple-negative breast cancer
Open Access
- 15 March 2022
- journal article
- research article
- Published by The Korean Society of Pathologists and The Korean Society for Cytopathology in Journal of Pathology and Translational Medicine
- Vol. 56 (2) , 73-80
Abstract
Background: Triple-negative breast cancer (TNBC) has a relatively poor prognosis. Research has identified potential metabolic targets, including fatty acid metabolism, in TNBC. The absence of effective target therapies for TNBC led to exploration of the role of fatty acid synthetase (FASN) as a potential target for TNBC therapy. Here, we analyzed the expression of FASN, a representative lipid metabolism–related protein, and investigated the association between FASN expression and Ki-67 and the programmed death ligand 1 (PD-L1) biomarkers in TNBC.Methods: Immunohistochemical expression of FASN was analyzed in 166 patients with TNBC. For analytical purposes, patients with 0–1+ FASN staining were grouped as low-grade FASN and patients with 2–3+ FASN staining as high-grade FASN.Results: FASN expression was observed in 47.1% of TNBC patients. Low and high expression of FASN was identified in 75.9% and 24.1%, respectively, and no statistically significant difference was found in T category, N category, American Joint Committee on Cancer stage, or recurrence rate between the low and high-FASN expression groups. Ki-67 proliferation level was significantly different between the low and high-FASN expression groups. FASN expression was significantly related to Ki-67 as the level increased. There was no significant difference in PD-L1 positivity between the low- and high-FASN expression groups.Conclusions: We identified FASN expression in 166 TNBC patients. The Ki-67 proliferation index was positively correlated with FASN level, indicating higher proliferation activity as FASN increases. However, there was no statistical association with PD-L1 SP142, the currently FDA-approved assay, or FASN expression level.Keywords
Funding Information
- National Research Foundation of Korea (2019M3E5D3073475)
- Ministry of Science and ICT
This publication has 45 references indexed in Scilit:
- MicroRNAs and Triple Negative Breast CancerInternational Journal of Molecular Sciences, 2013
- Prognostic value of Ki-67 proliferating index in triple negative breast carcinomasPathology - Research and Practice, 2013
- Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011Annals of Oncology, 2011
- Histopathological subclassification of triple negative breast cancer using prognostic scoring system: five variables as candidatesVirchows Archiv, 2010
- Triple-Negative Breast CancerNew England Journal of Medicine, 2010
- Clinicopathological Feature and Recurrence Pattern of Triple Negative Breast CancerJournal of the Korean Surgical Society, 2010
- Triple-negative breast cancer—current status and future directionsAnnals of Oncology, 2009
- Epithelial-Mesenchymal Transition in Breast Cancer Relates to the Basal-like PhenotypeCancer Research, 2008
- Fatty acid synthase is a marker of increased risk of recurrence in endometrial carcinomaGynecologic Oncology, 2004
- Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasionNature Medicine, 2002